Gout Clinical Trials

71 recruiting

Gout Trials at a Glance

52 actively recruiting trials for gout are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Phase 2 with 10 trials, with the heaviest enrollment activity in Miami, Tampa, and Chicago. Lead sponsors running gout studies include Assistance Publique - Hôpitaux de Paris, Atom Therapeutics Co., Ltd, and Crystalys Therapeutics.

Browse gout trials by phase

Treatments under study

About Gout Clinical Trials

Looking for clinical trials for Gout? There are currently 71 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gout trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gout clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 52 trials

Recruiting
Not Applicable

The Remote Monitoring of Gout Feasibility Study in Primary Care

Gout
Diakonhjemmet Hospital50 enrolled1 locationNCT07490522
Recruiting
Phase 3

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

Tophaceous Gout
Crystalys Therapeutics250 enrolled78 locationsNCT07089888
Recruiting
Phase 3

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Gout
Crystalys Therapeutics500 enrolled95 locationsNCT07089875
Recruiting
Phase 4

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

GoutUric Acid
Seoul National University Hospital59 enrolled1 locationNCT06622603
Recruiting
Phase 1

Drug-Drug Interaction Study of ABP-671 in Gout Patients

GoutGout ChronicDDI (Drug-Drug Interaction)
Atom Therapeutics Co., Ltd20 enrolled1 locationNCT07367971
Recruiting
Not Applicable

Tight Control of Gouty Arthritis Compared to Usual Care

Gout
University of Edinburgh125 enrolled1 locationNCT05507723
Recruiting
Not Applicable

Dose Response of Exercise for Arthritis Management

ArthritisGoutRheumatoid Arthritis (RA)+3 more
University of South Carolina285 enrolled1 locationNCT06880653
Recruiting
Phase 2

A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

Acute Gouty Arthritis
TJ Biopharma Co., Ltd.170 enrolled1 locationNCT07453004
Recruiting
Phase 2

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd.340 enrolled1 locationNCT07362355
Recruiting
Phase 3

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Uncontrolled Gout
Amgen270 enrolled25 locationsNCT07388498
Recruiting
Not Applicable

The Effects of a Probiotic Food Supplement in Hyperuricaemia

Hyperuricemia With or Without Gout
Örebro University, Sweden99 enrolled1 locationNCT07141888
Recruiting

The Orienting Study

GoutCPPD - Calcium Pyrophosphate Deposition Disease
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio450 enrolled1 locationNCT07504146
Recruiting
Phase 3

Tigulixostat (IBI128) vs Febuxostat in Gout

Gout
Innovent Biologics Technology Limited (Shanghai R&D Center)600 enrolled1 locationNCT07414394
Recruiting
Not Applicable

Home Hospital for Suddenly Ill Adults

Heart FailureAsthmaChronic Kidney Diseases+6 more
Brigham and Women's Hospital3,000 enrolled2 locationsNCT03524222
Recruiting
Phase 2Phase 3

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Joint PainArthritisGout+4 more
Olatec Therapeutics LLC300 enrolled40 locationsNCT05658575
Recruiting
Phase 2

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

GoutGouty ArthritisHyperuricemia+4 more
Arthrosi Therapeutics25 enrolled8 locationsNCT07116746
Recruiting
Phase 2

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

Gout
Protalix150 enrolled1 locationNCT07280156
Recruiting

Time Required to Dissolve Urate Deposits

Gout
Assistance Publique - Hôpitaux de Paris250 enrolled1 locationNCT06669000
Recruiting
Phase 3

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration

Gout
University Hospital, Rouen128 enrolled6 locationsNCT05109936
Recruiting
Phase 4

Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

GoutGout ArthritisGout Flare
Massachusetts General Hospital150 enrolled1 locationNCT07346079